Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...

Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...

Are you ready for artificial intelligence (AI)-driven mRNA vaccines?

MRNA intends to use the funds to support the development of its mRNA-based bird flu shot and expand clinical studies for ...

Moderna ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Investing.com -- Moderna , Inc. (NASDAQ: MRNA )今日确认，该公司已赢得为欧盟 (EU)、挪威和北马其顿供应其mRNA新冠疫苗的招标。这项有效期长达四年的协议允许17个国家获得Moderna疫苗。

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to ...

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...